| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Recent advancements in innovative product development at Novartis are driving the pharmaceutical sector forward, particularly with the introduction of Rhapsido, a groundbreaking treatment for chronic friction hives. The strong focus on RNA therapeutics and the expansion of access to chronic skin condition treatments emphasize the company's commitment to addressing unmet medical needs. License agreements are also becoming increasingly vital in facilitating drug development and enhancing innovation. Overall, Novartis's proactive approach positions it favorably within the competitive landscape of pharmaceutical innovation. |
| The price action of Novartis AG (NVS) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.4 is modestly bullish. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. NVS is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 0.7, and the negative at -0.2 on 2026-10-07. The forces of Sentiment towards Fundamentals (2.3), Option Sentiment (1.5), Stock Price Trend (0.4), Market Risk Appetite (0), and Price Level Sentiment (0) will drive up the price. The forces of Sector Price Trend (-0.2), and Valuation Sentiment (-1) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| NVS | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-07 | 0%(0%) | 143.26 | 1.88% | 69 | 63 | 75 | 1.77% | 0.14% | 0.4 | 0.1 | 1% | 0.5 | Long | 55% | 2.3 | 7 |
| 2026-10-06 | 0%(0%) | 140.77 | 1.95% | 49 | 57 | 65 | -0.09% | 0% | -1.1 | 0 | 0.3% | -0.2 | Short | 55% | -0.1 | -1 |
| 2026-10-05 | 0%(0%) | 140.9 | 3.54% | 45 | 56 | 52 | -0.04% | 0% | -1.2 | 0.1 | 0.4% | -0.7 | Wait | 50% | -0.7 | -1 |
| 2026-10-04 | 0%(0%) | -1 | 0.1 | -1.2 | -1.9 | -1 | ||||||||||
| 2026-10-03 | 0%(0%) | -1 | 0.1 | -1.2 | -1.9 | -1 | ||||||||||
| 2026-10-02 | 0%(0%) | 140.96 | 4.82% | 42 | 61 | 35 | -0.07% | 0% | -1 | -0.2 | 0.8% | -1 | Short | 55% | -1.9 | -1 |
| 2026-10-01 | 0%(0%) | 141.06 | 5.66% | 41 | 60 | 16 | -1.1% | 0.14% | -0.8 | -0.5 | 1.1% | -1.2 | Short | 55% | -4.1 | -1 |
| 2026-09-30 | 0%(0%) | 142.63 | 6.16% | 43 | 66 | 28 | -2.11% | 0.28% | 0.1 | -0.5 | 0.9% | -0.9 | Short | 55% | -1.9 | -1 |
| 2026-09-29 | 0%(0%) | 145.7 | 6.1% | 51 | 80 | 41 | -0.84% | 0.49% | 0.6 | 0.2 | 0.5% | -0.5 | Long | 55% | -0.7 | -1 |
| 2026-09-28 | 0%(0%) | 146.93 | 6.17% | 53 | 31 | 76 | 1.01% | 0.71% | 0.9 | 0.4 | 0.8% | 1.6 | Long | 55% | 2.7 | -1 |
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Analysis | ||
| ● Novartis AG (NVS) Equity Research Report Wed. Mar 11, 2026 | ||
| 2026-10-07 17:07:53 The positive movement in Novartis' stock reflects strong market confidence and expectations for future earnings. |
| 2026-10-07 17:07:53 The advancements in drug use point to a growing trend in the pharmaceutical industry towards better management of chronic conditions. |
| 2026-10-07 17:07:53 Novartis is developing and increasing access to treatments for chronic skin conditions, showcasing innovation in their product pipeline. |
| 2026-10-07 17:07:53 Novartis' stock showed a positive movement, indicating investor confidence and good market performance. |
| 2026-10-07 17:07:53 The US FDA's decision to expand the use of Novartis' drug signifies regulatory approval that positively impacts treatment options for patients. |
| 2026-10-07 15:47:24 The introduction of Rhapsido as the first treatment specifically targeting chronic friction hives represents significant innovation in the pharmaceutical industry. |
| 2026-10-07 15:47:24 The approval of Novartis's Rhapsido by the FDA highlights the impact of regulatory bodies on the availability of new treatments for conditions like chronic hives. |